Journal article

2017 international meeting of the Global Virus Network

Mike Catton, Glenda Gray, Diane Griffin, Hideki Hasegawa, Stephen J Kent, Jason Mackenzie, Edward McSweegan, Natalia Mercer, Linfa Wang

Antiviral Research | ELSEVIER SCIENCE BV | Published : 2018

Abstract

The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 40 GVN Centers of Excellence and 6 Affiliate laboratories in 24 countries. The 2017 meeting was held from September 25-27 in Melbourne, Australia, and was hosted by the Peter Doherty Institute for Infection and Immunity and the Institut Pasteur. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including the recent Zika epidemic, infections by human papillomavirus, influenza, HIV, hepatitis C, HTLV-1, and chikungunya viruses, and new and..

View full abstract

Grants

Funding Acknowledgements

We thank the participants who presented their data at the 2017 International GVN Meeting. We thank The Peter Doherty Institute for Infection and Immunity, and the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) for their outstanding management of the meeting and related events. Support also was provided by numerous sponsors, including, Abbvie, the Australian Centre for HIV and Hepatitis Virology Research (ACH<SUP>2</SUP>), the Australian Centre for Hepatitis Virology, Bioniz, Club Melbourne, CSL Limited, FORT National Biopharmaceutical Company, Gilead, The Institute of Human Virology/Nigeria, the Melbourne Convention Exhibition Centre, and ViiV Healthcare.